Study of Ridaforolimus (MK-8669) in Participants With Solid Tumors (MK-8669-003)(COMPLETED)
Clinical trial NCT00694083 · COMPLETED
Trial details
- NCT number
- NCT00694083
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-10
- Primary completion
- 2009-09-06
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.